A detailed history of Yousif Capital Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Yousif Capital Management, LLC holds 80,167 shares of OGN stock, worth $1.19 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
80,167
Previous 83,683 4.2%
Holding current value
$1.19 Million
Previous $1.73 Million 11.49%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$18.65 - $23.03 $65,573 - $80,973
-3,516 Reduced 4.2%
80,167 $1.53 Million
Q2 2024

Jul 31, 2024

SELL
$17.45 - $21.96 $202,280 - $254,560
-11,592 Reduced 12.17%
83,683 $1.73 Million
Q1 2024

Apr 26, 2024

SELL
$13.78 - $18.8 $141,038 - $192,418
-10,235 Reduced 9.7%
95,275 $1.79 Million
Q4 2023

Feb 01, 2024

BUY
$10.95 - $17.32 $773,387 - $1.22 Million
70,629 Added 202.49%
105,510 $1.52 Million
Q3 2023

Oct 30, 2023

SELL
$16.59 - $23.77 $6,503 - $9,317
-392 Reduced 1.11%
34,881 $605,000
Q2 2023

Aug 02, 2023

BUY
$19.27 - $24.63 $48,849 - $62,437
2,535 Added 7.74%
35,273 $734,000
Q1 2023

May 02, 2023

SELL
$21.42 - $32.08 $55,970 - $83,825
-2,613 Reduced 7.39%
32,738 $769,000
Q4 2022

Jan 09, 2023

SELL
$23.31 - $28.61 $19,930 - $24,461
-855 Reduced 2.36%
35,351 $0
Q3 2022

Nov 04, 2022

BUY
$23.4 - $34.25 $11,185 - $16,371
478 Added 1.34%
36,206 $847,000
Q2 2022

Aug 01, 2022

SELL
$31.66 - $38.9 $37,390 - $45,940
-1,181 Reduced 3.2%
35,728 $1.21 Million
Q1 2022

May 12, 2022

SELL
$30.45 - $39.36 $68,390 - $88,402
-2,246 Reduced 5.74%
36,909 $1.29 Million
Q4 2021

Jan 31, 2022

BUY
$28.67 - $37.13 $1.12 Million - $1.45 Million
39,155 New
39,155 $1.19 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.79B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.